P-092: Multiple Myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival
Tianzeng Chen(Brigham and Women's Hospital), Giada Bianchi(Brigham and Women's Hospital), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Kenneth C. Anderson(Dana-Farber Cancer Institute), Maria Moscvin(Brigham and Women's Hospital), Matthew Ho(Mayo Clinic), Keith E. Blackwell(University of California, Los Angeles), Jenna Briere(Dana-Farber Cancer Institute)
Cited by 0
Related Papers
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k